Researchers Provide a Better Understanding of sJIA and Still’s Disease
Sourced from publicdomainpictures.net (https://www.publicdomainpictures.net/en/view-image.php?image=275669&picture=chemical-research)

Researchers Provide a Better Understanding of sJIA and Still’s Disease

According to Healio, medical professionals from Boston Children's Hospital have conducted research that provides a better look at systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease. They looked specifically…

Continue Reading Researchers Provide a Better Understanding of sJIA and Still’s Disease
First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
DarkoStojanovic / Pixabay

First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601

Amolyt Pharma has recently announced that they have dosed the first patient in their trial of AZP-3601, a treatment for hypoparathyroidism. According to GlobeNewswire, this treatment will adequately address the…

Continue Reading First Patient Dosed in Trial of Hypoparathyroidism Treatment, AZP-3601
Mouse Study Reveals Possible Therapy for Charcot-Marie-Tooth Disease
source: pixabay.com

Mouse Study Reveals Possible Therapy for Charcot-Marie-Tooth Disease

Researchers have recently conducted a study using mouse models of Charcot-Marie-Tooth (CMT) disease, titled "CMTM6 Expressed on the Adaxonal Scwann Cells Surface Restricts Axonal Diameters in Peripheral Nerves." It was…

Continue Reading Mouse Study Reveals Possible Therapy for Charcot-Marie-Tooth Disease

Dystrophic Epidermolysis Bullosa Treatment Receives Fast Track Designation

The FDA has recently granted the Fast Track designation to AGLE-102, a treatment for dystrophic epidermolysis bullosa. This designation will allow for the treatment to reach patients at a quicker…

Continue Reading Dystrophic Epidermolysis Bullosa Treatment Receives Fast Track Designation
FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment
stevepb / Pixabay

FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment

The FDA has recently granted the Breakthrough Therapy designation to FARXIGA, a chronic kidney disease treatment created by AstraZeneca. This designation will allow for a quicker development, which will hopefully…

Continue Reading FDA Grants Breakthrough Therapy Designation for Chronic Kidney Disease Treatment
Duke and Seelos Therapeutics to Work on Parkinson’s Disease Gene Therapy
Aymanejed / Pixabay

Duke and Seelos Therapeutics to Work on Parkinson’s Disease Gene Therapy

Seelos Therapeutics and Duke University have both signed a Sponsored Research Agreement, meaning they will work in tandem to evaluate and test SLS-004, a Parkinson's disease treatment. Their research aims…

Continue Reading Duke and Seelos Therapeutics to Work on Parkinson’s Disease Gene Therapy
Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
source: pixabay.com

Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis

A study reported in NewsWise evaluates retinoid-x receptor (RXR) agonists as a treatment for recurring and refractory multiple sclerosis (MS). This specific RXR agonist, bexarotene, was found to help remyelination,…

Continue Reading Retinoid-X Receptor Agonist as a Treatment for Multiple Sclerosis
Vertex Will Present Data on CFTR Modulators as Treatments for Cystic Fibrosis
source: pixabay.com

Vertex Will Present Data on CFTR Modulators as Treatments for Cystic Fibrosis

Vertex Pharmaceuticals will present data on the long-term use of their cystic fibrosis (CF) treatments at the 43rd European Cystic Fibrosis Digital Conference, and then again at the 2020 North…

Continue Reading Vertex Will Present Data on CFTR Modulators as Treatments for Cystic Fibrosis
A New Genetic Mutation Has Been Connected to Pulmonary Arterial Hypertension
source: pixabay.com

A New Genetic Mutation Has Been Connected to Pulmonary Arterial Hypertension

Medical professionals have already discovered a number of genes that play a role in pulmonary arterial hypertension (PAH), but according to LabRoots, they have found a new one. The ABCC8…

Continue Reading A New Genetic Mutation Has Been Connected to Pulmonary Arterial Hypertension
Close Menu